BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6140869)

  • 1. Strategies for enhancing drug therapy of schizophrenia.
    Schooler NR; Levine J
    Am J Psychother; 1983 Oct; 37(4):521-32. PubMed ID: 6140869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies.
    Schooler NR; Keith SJ; Severe JB; Matthews SM
    Psychiatr Q; 1995; 66(4):279-92. PubMed ID: 8584586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response of prophylactic antipsychotics.
    Davis JM; Kane JM; Marder SR; Brauzer B; Gierl B; Schooler N; Casey DE; Hassan M
    J Clin Psychiatry; 1993 Mar; 54 Suppl():24-30. PubMed ID: 8097195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of schizophrenia.
    Leucht S; Heres S; Kissling W; Davis JM
    Fortschr Neurol Psychiatr; 2013 May; 81(5):e1-13. PubMed ID: 23702802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 6. The natural course of schizophrenia and effective maintenance drug treatment.
    Davis JM; Andriukaitis S
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous versus intermittent neuroleptic therapy in schizophrenia.
    Jolley AG; Hirsch SR
    Drug Saf; 1993 May; 8(5):331-9. PubMed ID: 8099290
    [No Abstract]   [Full Text] [Related]  

  • 8. Conventional antipsychotic medications for schizophrenia.
    Dixon LB; Lehman AF; Levine J
    Schizophr Bull; 1995; 21(4):567-77. PubMed ID: 8749885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse.
    Sulliger N
    J Psychosoc Nurs Ment Health Serv; 1988 Jun; 26(6):20-3. PubMed ID: 2905745
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 11. Good medical practice in antipsychotic pharmacotherapy.
    Peuskens J
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S35-41. PubMed ID: 9690969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Lemke M; Heuser I; Maier W; Huff W; Schmitt A; Sauer H; Riedel M; Klingberg S; Köpcke W; Ohmann C; Möller HJ;
    J Clin Psychiatry; 2011 Feb; 72(2):205-18. PubMed ID: 20673559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent medication, coping and psychotherapy. Interactions in relapse prevention and course modification.
    Müller P; Bandelow B; Gaebel W; Köpcke W; Linden M; Müller-Spahn F; Pietzcker A; Schaefer E; Tegeler J
    Br J Psychiatry Suppl; 1992 Oct; (18):140-4. PubMed ID: 1356364
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychotic recurrence after antipsychotic discontinuation.
    Zipursky RB
    Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
    [No Abstract]   [Full Text] [Related]  

  • 17. Compliance, quality assurance and standards for relapse prevention in schizophrenia.
    Kissling W
    Acta Psychiatr Scand Suppl; 1994; 382():16-24. PubMed ID: 7916524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The problem of drug compliance in schizophrenic patients].
    Albus M
    Psychiatr Prax; 1995 Nov; 22(6):221-2. PubMed ID: 8570750
    [No Abstract]   [Full Text] [Related]  

  • 19. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
    Hogarty GE
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication adherence studies in schizophrenia.
    Hamann J; Pitschel-Walz G; Kissling W
    Am J Psychiatry; 2004 Mar; 161(3):582; author reply 582-3. PubMed ID: 14992997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.